Online tool to accelerate COVID-19 research

tellic graph.C19 helped groups across biopharma and academia expedite COVID-19 research

Over the past three months, usage of tellic graph.C19 has exceeded our expectations, and we are grateful to have been able to help scientists connect the dots across COVID-19 research.

As many users shift research to priorities outside of COVID-19, we will also be returning our focus to academic and biopharma collaborations for building user-specific graph applications to answer biomedical questions.

As planned, after June 30, 2020, we will no longer be supporting the tellic graph.C19 instance and those accounts will no longer be active.

Learn more

The challenge of refining raw biomedical data at three sequential levels

Access our analysis here and keep up to date as you build your biomedical data strategy

The growing volume of biomedical data needs refinement to enable actionable insights.

Challenge 123

tellic has worked on finding optimal ways to refine biomedical data for five years in collaboration with numerous pharma and academic stakeholders. We defined three levels of necessary data refinement:

Entity
Relationship
Property